Oncology Nursing News
Panelists discuss how amivantamab’s dual targeting of EGFR and MET may address resistance mechanisms and unmet needs in EGFR-mutated advanced non–small cell lung cancer (NSCLC), with Dr Scott highlighting its potential clinical benefits, while Squires shares insights on managing the adverse event profile and strategies for managing adverse effects in patients receiving intravenous (IV ...
News
Niraparib plus dostarlimab with platinum-based chemotherapy achieved superior PFS, meeting the primary end point of the phase 3 FIRST-ENGOT-OV44 trial.
Oncology Nursing News Top Stories: August 2023
In August 2023, a retrospective analysis suggest that bladder-sparing radiotherapy can yield survival outcomes that are equivalent to radical cystectomy in select patients with bladder cancer; the FDA granted accelerated approval to elranatamab-bcmm (Elrexfio) as a treatment for patients with relapsed or refractory multiple myeloma; and an …
FDA Approves Encorafenib Plus Cetuximab and Chemo in BRAF …
2024年12月20日 · The FDA has granted accelerated approval to encorafenib (Braftovi), cetuximab (Erbitux), and mFOLFOX6 for patients with BRAF V600E-mutated metastatic colorectal cancer, as detected by an FDA-approved test. 1. The regulatory decision was supported by data from the phase 3 BREAKWATER trial (NCT04607421), which showed that patients treated with encorafenib plus cetuximab and mFOLFOX6 achieved an ...
Oncology Nursing News Top Stories: April 2023
In April 2023, new research suggested that nurses may be able to extend the flush times for implanted vascular access devices; 4 gastrointestinal (GI) cancer specialists relayed their experiences in providing high quality care to patients with pancreatic cancer and cholangiocarcinoma; and findings from a study demonstrated that oncology nurses are well suited to encourage end-of-life ...
Oncology Nursing News
Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers. Mitazalimab Plus mFOLFIRINOX Improves Survival in Pancreatic Cancer. Novel ADC Shows Promise in Platinum-Resistant Ovarian Cancer
Oncology Nursing News Top Stories: January 2023
2023年2月1日 · Each month, Oncology Nursing News® takes a look back at our most popular stories.In January 2023, data presented at the 2022 San Antonio Breast Cancer Symposium continued to grab the attention of oncology nurses. Below, find links to poster presentations highlighting new innovations in tamoxifen-related symptom management, and an exclusive interview highlighting key nursing takeaways of ...
Oncology Nursing News
The FDA has approved zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. The prescribing label comes with warnings for hemorrhage, infections, cytopenias, second primary malignancies, and cardiac arrythmias.
Oncology Nursing News: Top Stories from 2022
2022年12月31日 · In 2022, various emerging topics grabbed the attention of our readers, from the feasibility of using neoadjuvant chemotherapy to make organ-sparing surgery more accessible for patients with rectal cancer, to using bioimpedance spectroscopy to proactively preventing chronic lymphedema, to the use of oral Minoxidil to treat later-stage alopecia in survivors, nurses showed an interest in ...
Oncology Nursing News Top Stories: September 2022
In September 2022, investigators published findings on an understudied stress associated with advanced cancer care—unmet death preferences. Many adolescent or young adult patients with cancer express that they would prefer to die at home; however, when combined with caregiver capabilities and necessary symptom management, most of these patients ultimately die in the hospital setting ...